patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: OK, whatz up with the spread?

"I like the potential product, short term funding + assets, the low float, and the bios of the folks involved"

I like all this too. The reverse split was not to my liking when it happened because of the reputation about reverse splits. But then we now have a really low float and the share price moves in a bigger way if someone wants in. I couldn't get to a dinner-presentation here in L.A. several months ago. I asked a friend with a doctor's degree in biology to attend for me. As a result he purchased shares too. One never knows what to expect, but the prospects here look pretty good to us. GLTAL ( now as to the mm's that is part of the game of day to day trading, we are thinking longer term.)

Share
New Message
Please login to post a reply